Yield10 Bioscience Stock Filter Stocks by Fundamentals
| YTEN Stock | USD 0.23 0.03 11.54% |
Yield10 Bioscience fundamentals help investors to digest information that contributes to Yield10 Bioscience's financial success or failures. It also enables traders to predict the movement of Yield10 Stock. The fundamental analysis module provides a way to measure Yield10 Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Yield10 Bioscience stock.
Yield10 | Shares Owned by Insiders |
Yield10 Bioscience Current Valuation Drivers
We derive many important indicators used in calculating different scores of Yield10 Bioscience from analyzing Yield10 Bioscience's financial statements. These drivers represent accounts that assess Yield10 Bioscience's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Yield10 Bioscience's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.5M | 13.7M | 23.3M | 8.2M | 1.9M | 1.8M | |
| Enterprise Value | 1.3M | 13.9M | 21.1M | 8.5M | 4.0M | 3.8M |
Yield10 Bioscience Institutional Holders
Institutional Holdings refers to the ownership stake in Yield10 Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Yield10 Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Yield10 Bioscience's value.| Shares | Renaissance Technologies Corp | 2023-12-31 | 14.3 K | Hrt Financial Llc | 2023-12-31 | 12.2 K | Tower Research Capital Llc | 2023-12-31 | 10.3 K | Wells Fargo & Co | 2023-12-31 | 36.0 | Ifp Advisors, Llc | 2023-12-31 | 30.0 | Vima Llc | 2023-12-31 | 12.0 | Salem Investment Counselors Inc | 2023-12-31 | 4.0 | Concord Wealth Partners | 2023-09-30 | 0.0 | Fmr Inc | 2023-09-30 | 0.0 | Cannell Peter B & Co Inc | 2023-12-31 | 248.1 K | Geode Capital Management, Llc | 2023-12-31 | 62.5 K |
Yield10 Fundamentals
| Return On Equity | -15.08 | ||||
| Return On Asset | -1.5 | ||||
| Operating Margin | (240.28) % | ||||
| Current Valuation | 6.07 M | ||||
| Shares Outstanding | 15.4 M | ||||
| Shares Owned By Insiders | 12.60 % | ||||
| Shares Owned By Institutions | 3.96 % | ||||
| Number Of Shares Shorted | 940.87 K | ||||
| Price To Earning | (3.19) X | ||||
| Price To Book | 11.23 X | ||||
| Price To Sales | 79.63 X | ||||
| Revenue | 60 K | ||||
| Gross Profit | (7.3 M) | ||||
| EBITDA | (14.13 M) | ||||
| Net Income | (14.46 M) | ||||
| Cash And Equivalents | 10.16 M | ||||
| Cash Per Share | 2.07 X | ||||
| Total Debt | 3.18 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | (0.21) X | ||||
| Cash Flow From Operations | (10.07 M) | ||||
| Short Ratio | 0.16 X | ||||
| Earnings Per Share | (1.82) X | ||||
| Target Price | 0.5 | ||||
| Number Of Employees | 29 | ||||
| Beta | 1.61 | ||||
| Market Capitalization | 3.74 M | ||||
| Total Asset | 3.91 M | ||||
| Retained Earnings | (414.15 M) | ||||
| Working Capital | (3.46 M) | ||||
| Current Asset | 15.34 M | ||||
| Current Liabilities | 3.91 M | ||||
| Net Asset | 3.91 M |
About Yield10 Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Yield10 Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yield10 Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yield10 Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:Check out Yield10 Bioscience Piotroski F Score and Yield10 Bioscience Altman Z Score analysis. To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.Note that the Yield10 Bioscience information on this page should be used as a complementary analysis to other Yield10 Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Yield10 Stock analysis
When running Yield10 Bioscience's price analysis, check to measure Yield10 Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yield10 Bioscience is operating at the current time. Most of Yield10 Bioscience's value examination focuses on studying past and present price action to predict the probability of Yield10 Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yield10 Bioscience's price. Additionally, you may evaluate how the addition of Yield10 Bioscience to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Yield10 Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share 0.008 | Quarterly Revenue Growth (1.00) | Return On Assets (1.50) | Return On Equity (15.08) |
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.